Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Adding Cilostazol to Nimodipine Improving Neurological Outcome of Patients With Aneurysmal Subarachnoid Hemorrhage? A Randomized, Double Blind, Placebo-controlled Trial

NCT07144956 is registered in ClinicalTrials.gov with Centre Hospitalier St Anne as lead sponsor.

NCT NCT07144956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07144956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Adding Cilostazol to Nimodipine Improving Neurological Outcome of Patients With Aneurysmal Subarachnoid Hemorrhage? A Randomized, Double Blind, Placebo-controlled Trial
Lead sponsor
Centre Hospitalier St Anne
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 15, 2025
Completion date
December 14, 2029
Enrollment
630 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage